Skip to main content
. 2025 Mar 23;17(7):1076. doi: 10.3390/cancers17071076
mRCC Metastatic Renal Cell Cancer
IMDC International Metastatic RCC Database Consortium
TKIs Tyrosine Kinase Inhibitor
VEGF Vascular Endothelial Growth Factor
ICI Immune Checkpoint Inhibitor
PFS Progression-Free Survival
OS Overall Survival
HR Hazard Ratio
CI Confidence Interval
KPS Karnofsky Performance Status
CNS Central Nervous System
SII Systemic Immune-Inflammation Index
ORR Objective Response Rate
IQR Interquartile Range